AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

USNA · NYSE · Household & Personal Products

USANA Health Sciences

Makes supplements and kids wellness products across direct-selling and direct-to-consumer channels.

$14.04

After-hours close+0.01 (+0.07%)

At close$14.03(−0.50%)

Something off on this page? Send us feedback.

Profile

USANA Health Sciences, Inc.USNAConsumer Staples

Sells nutritional supplements, foods, skincare, and personal-care products through a direct-selling core, plus Hiya kids wellness through direct-to-consumer subscriptions. The business is weighted toward Asia Pacific and depends on Brand Partner retention, product compliance, China regulation, and the newer omni-channel mix.

Develops and manufactures science-based nutritional supplements, functional foods, personal-care products, and skincare under the Core nutritional segment. Hiya adds a U.S. children's health-and-wellness line built around direct-to-consumer subscriptions, with Rise adding protein-bar exposure outside the legacy channel.

Core nutritional is sold mainly through Brand Partners and Preferred Customers, while the broader platform now spans direct selling, direct-to-consumer, marketplace, and retail channels. Asia Pacific is the largest regional weight, with the Americas and Europe forming the other disclosed region.

Execution centers on formulation, in-house manufacturing, customer education, and compensation-plan management. The business depends on Brand Partner retention, China and other direct-selling rules, dietary-supplement and food compliance, and reputation in nutrition and direct selling.

Company facts

CEOKevin G. Guest

ListedJul 25, 1996

ExchangeNYSE

HeadquartersSalt Lake City, UT

CountryUnited States

Employees1,570

CIK0000896264

ISINUS90328M1071

Key statistics

Market cap$259.2M

EPS (ttm)−$1.21

P/E (ttm)−11.63

ROE-4.2%

P/B0.4931

P/S0.2838

Dividend yield—

Beta1.23vs XLP 0.94

Year to date −27.8% · Average volume (30d) 199.2K

Analysts

Price target, next 12 months$35.00+149.3%Median of 8 analysts · vs the Aug 28 close

ConsensusHold2 of 8 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $14.04

High$35.00+149.3%

Median$35.00+149.3%

Low$35.00+149.3%

12 months agoNowIn 12 months

Latest analyst notes

No analyst notes in the last 24 months.

Earnings

EPS

Estimate$0.11

ReportedDue Oct 28, 2026

Revenue

Estimate$219.0M

ReportedDue Oct 28, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 4, 2026Q2 FY26	$0.43	−$0.07	−116.3%	$235.0M	$223.3M	−5.0%	−34.20%
May 5, 2026Q1 FY26	$0.44	$0.61	+38.6%	$241.0M	$250.0M	+3.7%	+3.89%
Feb 17, 2026Q4 FY25	$0.41	$0.60	+46.3%	$226.0M	$226.2M	+0.1%	−8.03%
Oct 21, 2025Q3 FY25	$0.25	−$0.15	−160.0%	$219.8M	$213.7M	−2.8%	−0.57%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$249.5M	$235.8M	$213.7M	$226.2M	$250.2M	$223.3M
Gross profit	$188.8M	$177.9M	$164.9M	$176.8M	$190.8M	$174.9M
Operating income	$15.7M	$16.7M	$1.2M	$17.2M	$13.9M	−$20.0M
Net income	$9.4M	$9.7M	−$6.5M	−$1.8M	$7.5M	−$21.4M
Diluted EPS	$0.49	$0.52	−$0.36	−$0.10	$0.41	−$1.16
Gross margin	75.6%	75.4%	77.2%	78.2%	76.2%	78.3%
Operating margin	6.3%	7.1%	0.6%	7.6%	5.5%	-9.0%

Fiscal years (4-quarter sums)FY21 $1.19B · FY22 $998.6M · FY23 $921.0M · FY24 $854.5M · FY25 $925.3M

Revenue by product · Q4 FY25

All Other$6.0M · 100%

Revenue by geography · Q2 FY26

Asia Pacific$157.1M · 41%

Greater China$114.6M · 30%

Americas And Europe$66.1M · 17%

Southeast Asia Pacific$28.7M · 8%

North Asia$13.8M · 4%

Balance sheet, Jul 4, 2026Cash & short-term investments $168.6M · Total debt $0 · Total assets $703.2M · Shareholders' equity $526.3M

Dividends

No dividends on record.

Ownership

Institutions 63.16%11.66M sharesInsiders 0.75%138.7K sharesOther 36.09%6.66M shares

Shares outstanding 18.46M · Float 9.87M · 53.4% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
Gull Global Limited	7.41M	40.10%	13D	Mar 30, 2026
Wentz Myron W · 10 percent owner	7.41M	40.13%	Form 4	Sep 5, 2025
BlackRock, Inc.	1.55M	8.42%	13F	Aug 7, 2026
Pzena Investment Management LLC	1.21M	6.53%	13F	Aug 7, 2026
Renaissance Technologies LLC	958.5K	5.19%	13F	Aug 13, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
Jun 16, 2026	Brent Neidig	officer: CHIEF COMMERCIAL OFFICER	−5,002	$19.45
Jun 15, 2026	Brent Neidig	officer: CHIEF COMMERCIAL OFFICER	−909	$20.01
Jun 12, 2026	Brent Neidig	officer: CHIEF COMMERCIAL OFFICER	−1,602	$20.15
Jun 8, 2026	Paul A. Jones	officer: CHIEF PEOPLE OFFICER	−5,561	$18.50
Jun 1, 2026	John Turman Fleming	director	−2,450	$17.93